How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
Sjögren’s Myth Busters: Can You Detect Fact from Fiction on Emerging Therapies?
Chadwick R. Johr, MD
Spot the Difference: Acute vs. Subacute Cutaneous Lupus
Avery H. LaChance, MD, MPH, FAAD
A Visual Guide to Cutaneous Dermatomyositis
Early Arthritis Insights from the CATCH Cohort
Louis Bessette MD, FRCP(C), MSc
The Next Era of Psoriatic Arthritis Management
Laura Coates, MBChB, MRCP, PhD
Minimal Disease Activity: A Practical Target in Psoriatic Arthritis
Diagnosing Psoriatic Arthritis: A Real-World Case
Lawrence H. Brent
Unpacking the Complexity of Psoriatic Arthritis
Shared CD8+ T Cell Clones Link Skin and Joint Inflammation in Psoriatic Arthritis
Can We Prevent Psoriatic Arthritis Before Diagnosis?
Spotlight on Systemic Sclerosis: Pathophysiology, Presentation, & Emerging Evidence
Flavia Castelino, MD
Benjamin Korman, MD
Progress and Practical Limits with AI in Psoriatic Arthritis
Ryan Quigley
Navigating the Modern PsA Treatment Landscape
Rethinking SLE Treatment: Recent Approvals, Novel Targets, and What’s Next
Steve Jackson, PharmD
Marc Scherlinger, MD, PhD
Cadherin-6 in Focus: Existing Antibodies, Emerging Applications
Gary S. Firestein, MD
Loading...
We're glad to see you're enjoying Rheumatology Academy… but how about a more personalized experience?
Press cancel to remain on Rheumatology Academy. Press the link below or the continue button to keep going.